Marc Nasoff
18Patents
5h-index
27Co-inventors
66Inventor score
Filing activity: Jan 26, 1990 → Jun 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7229617B2 | Methods and compositions for inducing apoptosis in cancer cells | Human Necessities | 18 | Expired |
| US5030563A | Bacterial hypersecretion using mutant repressor sequence | Chemistry; Metallurgy | 11 | Expired |
| US9790280B2 | Monoclonal canine CD20 antibodies and methods of use | Chemistry; Metallurgy | 10 | Active |
| US6692751B1 | Methods and systems for producing recombinant viral antigens | Chemistry; Metallurgy | 5 | Expired |
| US8101182B2 | Methods and compositions for treating allergic diseases | Chemistry; Metallurgy | 5 | Active |
| US8097705B2 | Methods and compositions for treating allergic diseases | Chemistry; Metallurgy | 4 | Active |
| US6635441B2 | Multi-sample fermentor and method of using same | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7794946B1 | Microarray and uses therefor | Performing Operations; Transporting | 2 | Expired |
| US6723555B2 | Multi-sample fermentor and method of using same | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8173128B2 | Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibody | Human Necessities | 2 | Active |
| US7888483B2 | Antagonists of protease activated receptor-1 (PAR1) | Chemistry; Metallurgy | 1 | Active |
| US8012703B2 | Microarrays and uses therefor | Performing Operations; Transporting | 1 | Active |
| US11484604B2 | Immunoconjugates targeting CD46 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11319377B2 | Monoclonal antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US8637264B2 | Microarrays and uses therefor | Performing Operations; Transporting | 0 | Active |
| US7863008B2 | Method for detecting NANBV associated seroconversion | Emerging Cross-Sectional Technologies | 0 | Active |
| US12144888B2 | Immunoconjugates targeting CD46 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12049511B2 | Engineered CD46-specific effector cells and uses thereof in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.